Evaluation Study of Medical-Social Collaboration Model for Middle-aged and Older Adults With Depressive Symptoms
1 other identifier
interventional
192
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a medical-social collaboration model works to reduce depressive symptoms in middle-aged and older adults with subsyndromal depressive symptoms who are waiting for their first psychiatric appointment. Secondary outcomes of the study include reduced anxiety symptoms, reduced loneliness, reduced rumination, reduced self-criticism, improved self-reassurance, improved resilience, improved self-efficacy, improved health-related quality of life, as well as improved quality-adjusted life years, and reduced healthcare service utilisation. Researchers will compare a medical-social collaboration model to a self-management booklet. Participants will:
- Receive CBT-based stepped-care interventions through the medical-social collaboration model or a self-management booklet.
- Complete a survey about their mental health and service use every three months until their first psychiatric appointment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable depression
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 11, 2025
CompletedFirst Posted
Study publicly available on registry
July 14, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
July 17, 2025
July 1, 2025
1.8 years
July 11, 2025
July 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Depressive Symptoms
Patient Health Questionnaire-9 (PHQ-9); range 0-27; higher scores indicate higher levels of depressive symptoms (worse outcome)
Baseline, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months
Secondary Outcomes (4)
Changes in Anxiety Symptoms
Baseline, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months
Changes in Loneliness
Baseline, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months
Changes in Health Service Use
Baseline, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months
Changes in Health-Related Quality of Life
Baseline, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months
Other Outcomes (6)
Self-Criticism and Self-Reassurance
Baseline, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months
Rumination
Baseline, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months
Resilience
Baseline, 3 months, 6 months, 9 months, 12 months, 15 months, 18 months, 21 months
- +3 more other outcomes
Study Arms (2)
JC JoyAge stepped-care model
EXPERIMENTALUsual care with minimal support
OTHERInterventions
After initial clinical assessment, participants will be offered interventions based on their depressive symptom severity (Patient Health Questionnaire-9-item \[PHQ-9\]). Mild symptoms (PHQ-9=5-9): 6 weekly low intensity CBT-based group intervention sessions led by trained clinical social workers, with 2 booster sessions as necessary. Moderate symptoms (PHQ-9=10-14): 6 weekly high intensity CBT-based group intervention sessions led by trained clinical social workers, with 2 booster sessions as necessary. Moderately severe symptoms (PHQ-9≥15): high intensity individual or group CBT-based intervention. Trained peer supporters will be matched to participants to walk them through the process with regular follow-up.
The booklet incorporates components of behavioural activation, which encourages participants to engage in meaningful activities in daily life to change their mood. Trained research assistants will regularly check in with the participants to monitor their depressive symptoms.
Eligibility Criteria
You may qualify if:
- Currently awaiting psychiatric services provided by the Hospital Authority
- Have depressive symptoms of at least mild severity
- Able to provide informed consent
You may not qualify if:
- A known history of autism spectrum disorder, intellectual disability, schizophrenia-spectrum disorder, bipolar disorder, Parkinson's disease, or dementia
- Communication difficulties that preclude participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The University of Hong Konglead
- Hospital Authority Hong Kong West Clustercollaborator
- Hospital Authority Hong Kong East Clustercollaborator
- Hospital Authority Kolwoon Central Clustercollaborator
Study Sites (1)
The University of Hong Kong
Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Terry YS Lum, PhD
The University of Hong Kong
- PRINCIPAL INVESTIGATOR
Gloria HY Wong, PhD
University of Reading
- PRINCIPAL INVESTIGATOR
Wai Chi Chan, MBChB
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Masking was no possible in this study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 11, 2025
First Posted
July 14, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
July 17, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared due to participant confidentiality reasons.